Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Allogene Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ALLO
Nasdaq
2836
allogene.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Allogene Therapeutics, Inc.
Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis
- Dec 15th, 2025 3:39 pm
December 2025 Penny Stocks Worth Watching
- Dec 12th, 2025 11:05 am
November 2025's Promising Penny Stocks To Watch
- Nov 12th, 2025 11:05 am
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
- Nov 10th, 2025 6:30 am
Allogene Posts Narrower-Than-Expected Loss in Q3, Nil Sales
- Nov 7th, 2025 9:20 am
Allogene Therapeutics Inc (ALLO) Q3 2025 Earnings Call Highlights: Strategic Advances and ...
- Nov 6th, 2025 10:11 pm
Allogene Therapeutics: Q3 Earnings Snapshot
- Nov 6th, 2025 2:26 pm
Allogene Therapeutics Reports Third Quarter 2025 Financial Results and Business Update
- Nov 6th, 2025 2:05 pm
Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting
- Nov 3rd, 2025 7:04 am
Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update
- Oct 30th, 2025 6:30 am
TVRD Stock Plunges 84% After Phase II Fibrosis Study Misses Key Goals
- Oct 14th, 2025 9:24 am
Allogene Therapeutics Faces Patent Infringement Challenges
- Oct 14th, 2025 9:09 am
CDTX Stock Up on FDA's Breakthrough Therapy Tag for CD388 in Influenza
- Oct 10th, 2025 10:21 am
OVID Stock Soars 39% in a Month Following Upbeat Epilepsy Study Data
- Oct 10th, 2025 8:27 am
KALA Stock Crashes 88% in a Month Following Eye Disorder Study Failure
- Oct 8th, 2025 9:18 am
AstraZeneca's Baxdrostat Meets Goal in Resistant Hypertension Study
- Oct 8th, 2025 9:15 am
September 2025's Promising Penny Stocks Revealed
- Sep 29th, 2025 12:05 pm
Krystal Biotech Stock Up on FDA Nod to Vyjuvek Label Update
- Sep 16th, 2025 10:54 am
Allogene Therapeutics Announces Participation in Upcoming Investor Conference
- Aug 27th, 2025 6:30 am
Discover Promising Penny Stocks This August 2025
- Aug 27th, 2025 6:08 am
Scroll